California Life Sciences is a non-profit organization that empowers the life sciences community to solve some of the world’s greatest challenges. We advocate for the industry and its diverse innovation pipeline. We propel solutions forward, so big dreams can make an even bigger impact. All of this adds up to people everywhere living longer, healthier, happier lives. And it’s all happening here. Together, we are California Life Sciences.

Catalent Biologics is keenly aware that every biologic drug has different needs and challenges. That is why we provide comprehensive solutions from development and biomanufacturing to fill/finish and packaging for new biological entities, cell and gene therapies, biosimilars, sterile injectables and antibody-drug conjugates. We attract some of the best experts in the industry, and that’s why our employees are committed to driving service excellence and actively contributing to a “Patient-First” culture, putting the patient at the center of everything we do.

MilliporeSigma is a global science and technology company determined to solve the toughest problems in life science. Our tools, services, and digital platforms empower scientists and engineers at every stage, helping to deliver scientific breakthroughs. The Life Science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada.

Pioneer your pathway discovery with SYNTHIA™ retrosynthesis software and leverage an ever-expanding reaction database and advanced algorithms to quickly identify viable and unique synthetic routes to target molecules based on your search criteria.

SCIEX‘s global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of scientists and lab analysts worldwide focused on drug discovery and development, clinical research, basic research, and other areas.

With over 40 years of innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis.

Learn more about SCIEX here.

Sai Life Sciences is one of India’s fastest growing Contract Research, Development & Manufacturing Organizations. As a pure-play, full-service CRO-CDMO, we work with over a 100 global innovator pharma and biotech companies to accelerate the discovery, development, and commercialisation of their NCE small molecule programmes.
Over the past two decades, Sai Life Sciences has served a diverse set of programmes, consistently delivering value based on its quality and responsiveness. Today, Sai has over 2000 employees across its facilities in India, UK and USA.

The Pharmaceutical & BioScience Society is a non-profit professional organization of scientists and other professionals in the life science sector, working in diverse organizations such as the biotechnology and pharmaceutical industries, instrumentation and scientific product suppliers, academia, government laboratories and contract research organizations. PBSS has 5000+ members and is active through five member organizations in San Francisco Bay Area, San Diego Area, Boston, Vancouver and Korea, some of the largest life science clusters in the World.

Asha means Hope. Asha’s vision is to bring hope in the lives of patients by enhancing the bioavailability of new drugs, helping them get to the market faster and reducing drug development costs. We work with our clients through the solid form screening and selection process. Our innovative and efficient proprietary workflows help discover new solid forms (polymorphs, salts and cocrystals) of pharmaceutical molecules and enhance bioavailability of poorly soluble drugs. We aspire to be the best in class solid form research company in the world.

Hypha Discovery is a specialist CRO supporting pharmaceutical companies worldwide through the production of metabolites and late-stage derivatives of drugs in discovery and development.
We are experts in the scalable synthesis, purification and identification of drug metabolites and oxidised derivatives of lead compounds, and also possess a wealth of experience in the production, purification and structure elucidation of natural products.

Advanced ChemBlocks Inc was founded by a drug discovery scientist in 2010, is located in the San Francisco Bay Area, is a leading worldwide chemical supplier of novel building blocks for drug discovery. Our mission is to deliver the latest and most innovative molecules to support our worldwide clients in drug discovery and biological research.

About 40,000 products are available and can be delivered in 1-10 days. Product quality is of paramount importance, we aim to offer compounds with the highest quality and purity.

Excelra is a preferred data and analytics partner to over 90 global clients, including 16 of the top 20 large Pharma, over 18 years.

Our Global Online Structure Activity Relationship Database (GOSTAR) is a one-stop data source, containing small molecule properties including SAR, physicochemical, metabolic, ADME and tox. profiles. The database is manually curated by our scientific teams who excerpt and enrich datasets from functional assays, in vitro and in vivo studies.

Learn more about GOSTAR here.

iPRECIO Programmable Pumps by Primetech Corporation help the life sciences community get the most out of their in-vivo pharmacology studies. The iPRECIO® mission is to make it as easy as possible to evaluate drug efficacy in animal models in a clinically relevant manner.

iPRECIO® pumps make it easier to determine exposure profiles and do quantitative pharmacology experiments with untethered, free-moving animals. Investments in iPRECIO® pumps significantly reduce costs by avoiding uninformative non-quantitative animal studies during development. We’re proud to help drug hunters break Eroom’s Law. Learn how in this On-Demand Webinar.

Chemspace is the largest online catalogue of small molecules: Building Blocks, Fragments, Screening Compounds, Reagents, and Intermediates. We also provide sourcing and procurement services which may include FTE- and FFS-based programs. Our goal is to deliver high-quality products to our customers for speeding up their research projects.

We understand your needs and guarantee molecules delivery in the required amount with high purity and always on time.

Pelago Bioscience is your drug discovery research partner, unleashing drug discovery with our expertize in biologically relevant assay systems.

Our unique core technology; the Cellular Thermal Shift Assay (CETSA®) allows assessment and quantification of target engagement under physiological conditions – without the need to modify the compound or protein.

Our approach is designed to help you make better decisions faster, no matter where you are in the drug discovery process.

With over 3600 customer-centric employees, operations and commercial offices across the US, EU and China, Porton Pharma Solutions provides global pharmaceutical companies with innovative, reliable and end-to-end process R&D and manufacturing services across small molecule APIs, dosage forms and biologics.

Our Process Technology Centers and WHO/USFDA/EMA/PDMA/NMPA-inspected Manufacturing Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets, plus over 500 highly skilled scientists and process engineers, all backed by a proven program management system dedicated to seamlessly delivering successful outcomes for your unique project requirements.

BirdoTech is a multi-ton capable, state-of-the-art CRO/CDMO that partners with the world’s top pharmaceutical companies to address worldwide healthcare needs. We’ve been tested to meet time sensitive deadlines supporting critical clinical trials. With 20,000 sq. meters of R&D lab space over 3 sites in China, our partners gain maximum flexibility in medicinal chemistry SAR, synthetic route scouting, process optimization, and production to multi-ton scale.

Sinocompound is a global provider of advanced homogeneous catalysts and ligands and specialist services for a range of pharmaceutical and fine chemical applications. We have expertise ranging from R&D all the way through to scale-up and commercial manufacturing. Our proven process is built around our next generation technologies, flexibility, and speed-of-response ensuring delivery at the scale required for your project. Our success is due to our dedication to listening to customers and developing bespoke solutions that help the industry overcome its challenges and customers accelerate their route to market. In order to facilitate this process further, we also offer catalyst screening and custom synthesis services.

Find out how to scale your product when limited by catalyst availability here.

Our story started in 2008 when Prof. Jouko Yliruusi and Prof. Edward Hæggström first combined their respective expertise in pharmaceutical technology and physics. This extraordinary collaboration produced a novel particle engineering technology with the ability to transform the pharmaceutical industry.

They discovered the Controlled Expansion of Supercritical Solutions (CESS®) process in 2012 at the University of Helsinki and Nanoform was founded in 2015. Since then, Nanoform has expanded rapidly, transforming into a company with global ambition. Our cutting edge nanoforming services is intended to help the global pharmaceutical industry to double its annual new medicines output. We are proud to be a Finnish success story with an international outlook.

BIOVIA solutions create an unmatched scientific management environment that can help science-based organizations create and connect biological, chemical and material innovations to improve the way we live.

The industry-leading BIOVIA portfolio integrates the diversity of science, experimental processes and information requirements, end-to-end, across research, development, QA/QC and manufacturing. Capabilities include Scientific Informatics, Molecular Modeling/Simulation, Data Science, Laboratory Informatics, Formulation Design, BioPharma Quality & Compliance and Manufacturing Analytics.

BIOVIA is committed to enhancing and speeding innovation, increasing productivity, improving quality and compliance, reducing costs and accelerating product development for customers in multiple industries.

Analiza, Inc. is a leading contract research organization dedicated to discovering, developing, and commercializing new technologies for the life sciences. Analiza provides integrated solutions to key applications in the pharmaceutical, biotechnology and diagnostics industries.

CAS is a specialist in scientific information solutions and knowledge management services who has partnered with innovators around the world for over 100 years to accelerate breakthroughs. CAS employs over 1,400 scientists and technologists who curate, connect, and analyze the world’s published science in more than 50 languages to reveal the unseen connections between researchers’ work. CAS is a division of the American Chemical Society.

Apex Molecular is a synthetic chemistry contract research organisation providing specialist synthesis services for the pharmaceutical, biotechnology (life sciences) and applied chemical sectors. The company was founded in 2011, moving to state-of-the-art facilities formerly occupied by AstraZenca at Alderley Park in Cheshire, UK in 2015.

Bio-Techne Corporation develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. The company's brands include R&D Systems, ProteinSimple, and Novus Biologicals.

At Biognosys, we believe that deep proteome insights hold the key to breakthrough discoveries that can dramatically improve human health. We enable life science researchers and drug hunters to look at the proteome from every angle with our versatile portfolio of proprietary proteomics services, software, and kits. These solutions provide a multi-dimensional view of protein expression, function, and structure in all biological species and sample types. Through advanced data analytics, Biognosys translates data into actionable insights for R&D and clinical research.

BIO is the world's largest biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. Our mission is to be the champion of biotechnology and the advocate for our member organizations—both large and small.

BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. We also represent state and regional biotech associations, service providers to the industry and academic centers.

Charnwood Discovery is a leading provider of drug discovery services, from standalone customized solutions through to fully integrated programs that enhance the experience and success of complex drug discovery. Our collaborative and efficient approach ensures we add value across the drug discovery pipeline from target validation through to pre-clinical candidates. Whether you need a standalone or fully integrated solution our multidisciplinary teams provide innovation and excellence at every stage.

Confluence Discovery Technologies (CDT) is a full-service pharmaceutical contract research organization that focuses on early-stage drug discovery and development pursuits.

We believe that our individually tailored research solutions paired with our extensive experience in the pharmaceutical discovery and development process help us deliver unmatched partnerships to accelerate each of our client’s unique project goals.

CrystalsFirst’s unique technology platform enables customers and collaboration partners rapid access to high-fidelity chemical matter across different drug targets and binding modalities. The company offers its high-performance screening, protein, and structural biology platform to pharmaceutical and biotechnology companies for small molecule drug discovery.

Within the broad fields of structure-based drug discovery and fragment-based lead generation, the application of CrystalsFirst’s proprietary technology SmartSoak® provides rapid structural insights into numerous target interaction modes with atomic resolution. The company’s fast access to the highest resolution structural data and molecular design strategies support medicinal chemistry in the development of candidate molecules in a time- and cost-efficient way.

IRBM is an innovative research organization with decades of experience in translating nascent research into drug discovery programs. Our unique blend of broad expertise, global pharma heritage and passion for science successfully helps advance and accelerate your therapeutics from conception to the clinic.

When you make the invisible visible, the impossible is possible. Our scientific instruments and solutions help our customers to create a better world. Through chemical, physical and structural analysis of materials, they improve everything from the energies that power us and the materials we build with, to the medicines that cure us and the foods we enjoy.

We partner with many of the world’s biggest companies, universities and research organizations. They value us not only for the power of our solutions, but also for the depth of our expertise, collaboration and integrity.

Nanome is the ultimate interface for scientific discovery, starting with molecular data. Top R&D labs conduct cutting-edge research and make billion-dollar decisions in Nanome. But, Nanome isn’t just for experts, it’s also used by students and amateur scientists studying chemistry and biology. Anyone can build 3D molecules or simulate an entire protein made of hundreds of atoms, all in one collaborative environment. Transform the way you learn, design, and communicate molecular structures with Nanome. Available on the new Meta Quest Pro.

NuChem Sciences a Drug Discovery and Chemical Development Contract Organization that Transform Ideas Through Science with an unparalleled knowledge base and a truly unique collaborative process, NuChem propels the dream of a potential breakthrough into a workable reality by launching the Discovery Partner Program. Since August 2023, NuChem Sciences is now a Sygnature Discovery business.

Oncodesign Services is a Contract research organization (CRO) specializing in drug discovery and preclinical services. Founded in 1995, Oncodesign Services mission’ is to contribute to the discovery of innovative therapies with unmet medical needs, in particular in oncology, inflammation and infectious diseases. From target identification, hit-to-lead and lead optimization to IND filing,

Oncodesign Services support the R&D programs of customers globally (whether pharmaceutical companies, biotechs, public research institutions, etc.).

Ontotext is a software company with offices in Europe and USA. It is the semantic technology branch of Sirma Group. Its main domain of activity is the development of software based on the Semantic Web languages and standards, in particular RDF, OWL and SPARQL.

OpenBench is the first and only success-driven service for small molecule hit discovery.

Optibrium provides elegant software solutions for small molecule design, optimisation and data analysis. Optibrium’s lead product, StarDrop™, is a comprehensive suite of integrated software with a highly visual and user-friendly interface. StarDrop™ enables a seamless flow from the latest data through to predictive modelling and decision-making regarding the next round of synthesis and research, improving the speed, efficiency, and productivity of the discovery process. The company’s new Augmented Chemistry™ products and services deliver ground-breaking artificial intelligence technologies that continuously learn from all available data to supplement your experience and skills.

At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries.

Schrödinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas.

Schrödinger is deeply committed to investing in the science and talent that drive its computational platform. Schrödinger was founded in 1990 and is engaged with customers and collaborators in more than 70 countries.

Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development.

CCDC are world-leading experts in structural chemistry data, software and knowledge for materials and life science research and application. They specialise in the collation, preservation and application of scientific structural data for use in pharmaceutical discovery, materials development and research and education.